⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6158339 | 0.79 | — | — | |
| SCHEMBL10645911 | 0.79 | — | — | |
| SCHEMBL3322472 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL839758 | 0.76 | — | — | |
| SCHEMBL16192126 | 0.75 | — | — | |
| SCHEMBL28913437 | 0.75 | — | — | |
| SCHEMBL29046781 | 0.75 | ADRA2A (0.53) | — | |
| SCHEMBL189942 | 0.75 | — | — | |
| SCHEMBL8305509 | 0.75 | FPR2 (0.44) | — | |
| SCHEMBL10696546 | 0.75 | FPR2 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2643000-A2 | THERAPEUTIC PIPERAZINES | Dart Neuroscience (Cayman) Ltd (KY) | 2013-10-02 | — | — | EP | claimed |
| WO-2012040258-A2 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| US-20110065691-A1 | THERAPEUTIC PIPERAZINES | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2011-03-17 | — | — | US | claimed |
| US-9624200-B2 | Therapeutic piperazines | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2017-04-18 | — | — | US | disclosed |
| US-20150087645-A1 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. | 2015-03-26 | — | — | US | disclosed |
| US-8927546-B2 | Therapeutic piperazines | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2015-01-06 | — | — | US | disclosed |
| EP-2643000-A2 | THERAPEUTIC PIPERAZINES | Dart Neuroscience (Cayman) Ltd (KY) | 2013-10-02 | — | — | EP | disclosed |
| WO-2012040258-A2 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. (US) | 2012-03-29 | — | — | WO | disclosed |
| US-20110065691-A1 | THERAPEUTIC PIPERAZINES | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2011-03-17 | — | — | US | disclosed |
| WO-2009141738-A2 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2009-11-26 | — | — | WO | disclosed |
| CN-101001852-A | Pyrazole derivatives | DAIICHI SEIYAKU CO (JP) | 2007-07-18 | — | — | CN | disclosed |
| US-7054140-B2 | Electrolytic capacitor and electrode foil used for electrolytic capacitor | NIPPON CHEMI-CON CORP. (JP) | 2006-05-30 | — | — | US | disclosed |
| US-20040212950-A1 | Electrolytic capacitor and electrode foil used for electrolytic capacitor | NIPPON CHEMI-CON CORPORATION (JP) | 2004-10-28 | — | — | US | disclosed |
| EP-1398806-A1 | ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR&minus;USE ELECTRODE FOIL USED THEREFOR | Nippon Chemi-Con Corporation (JP) | 2004-03-17 | — | — | EP | disclosed |
| EP-0217372-A2 | Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-04-08 | — | — | EP | disclosed |
| US-4396530-A | Mineral acid demulsification of surfactant-containing emulsion | MARATHON OIL COMPANY (US) | 1983-08-02 | — | — | US | disclosed |